Researchers investigating early diagnostic indicators for neurodegenerative conditions have found that chemical signatures gathered from the human navel differ between healthy individuals and those diagnosed with Parkinson’s disease or mild cognitive impairment. Published as an exploratory investigation, the work examines whether volatile organic compounds emitted through skin oils and sweat can serve as non-invasive biomarkers.
Volatile Organic Compounds and Chemical Fingerprints in the Navel
The human body constantly releases tiny molecules known as volatile organic compounds through metabolic processes, which reach the skin surface via sweat and sebum. Because the navel naturally collects skin cells, sebum, sweat, and bacteria over time, researchers at the Fraunhofer Institute for Integrated Circuits IIS identified the region as a potential reservoir for a localized chemical fingerprint. Thorsten Graunke and his research team explored whether these distinct body odors could function as early warning signs for underlying systemic health changes.
Study Findings on Navel and Nasal Samples
To test this hypothesis, the study evaluated 24 participants divided evenly into four distinct groups: six individuals with Parkinson’s disease, six with mild cognitive impairment, six recovering from or diagnosed with Covid-19, and six healthy control subjects. Investigators collected swab samples from the navel, nose, and ear of each participant, subsequently analyzing the volatile compounds using laser-based measurement methods. The results demonstrated measurable differences across the groups, with the most pronounced distinctions appearing in samples taken from the nose and the navel. While navel samples showed the strongest divergence between healthy participants and those with mild cognitive impairment, the Parkinson’s samples fell between groups with partial overlaps. A subsequent round of three additional Parkinson’s samples collected two weeks later aligned with the previously recorded chemical patterns.
Expert Perspective and Limitations of Current Research
Prof. Dr. Christoph Kleinschnitz, director of the neurology clinic at University Hospital Essen and neurology professor at the University of Duisburg-Essen, notes that the biological mechanism is theoretically sound despite initial impressions. Because Parkinson’s disease impacts the autonomic nervous system and metabolism alongside motor control centers, and is known to alter skin sebum production and lipid metabolism, these physiological shifts could influence regional body odor. However, Kleinschnitz emphasizes that with a cohort of only six Parkinson’s patients, the medical community remains far from a validated clinical test. Study authors acknowledge that larger trials are required to isolate variables such as age, disease progression, and everyday environmental factors like soaps and perfumes from the underlying chemical signatures.
Worth a look